Immunis, Inc.
Immunis is a clinical stage regenerative medicine biotech developing a unique stem cell-derived biologic, a novel multi-active therapy targeting dysregulated immune-associated muscle aging and metabolic decline.
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
)
March 2-3, 2026 | Miami Beach
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
